DBV Technologies Correlations

DBVT Stock  USD 13.30  0.47  3.41%   
The current 90-days correlation between DBV Technologies and Larimar Therapeutics is 0.16 (i.e., Average diversification). The correlation of DBV Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

DBV Technologies Correlation With Market

Modest diversification

The correlation between DBV Technologies and DJI is 0.28 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding DBV Technologies and DJI in the same portfolio, assuming nothing else is changed.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DBV Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For more information on how to buy DBV Stock please use our How to Invest in DBV Technologies guide.

Moving together with DBV Stock

  0.79RAC Race OncologyPairCorr
  0.63VANI Vivani MedicalPairCorr
  0.62DNLI Denali TherapeuticsPairCorr
  0.74VERA Vera TherapeuticsPairCorr
  0.81DRUG Bright Minds BiosciencesPairCorr
  0.79CDIOW Cardio DiagnosticsPairCorr
  0.74DTIL Precision BioSciencesPairCorr
  0.63DWTX Dogwood Therapeutics,PairCorr
  0.82VKTX Viking TherapeuticsPairCorr

Moving against DBV Stock

  0.72DRMA Dermata TherapeuticsPairCorr
  0.57EQ EquilliumPairCorr
  0.47PYC Physiomics PlcPairCorr
  0.330P6S Bayer AG NAPairCorr
  0.31AVH Avita MedicalPairCorr
  0.84VPRO ViroproPairCorr
  0.8EGRX Eagle PharmaceuticalsPairCorr
  0.7300238 Guanhao BiotechPairCorr
  0.64ELUT Elutia IncPairCorr
  0.53SRZNW Surrozen WarrantPairCorr
  0.49MRVL Marvel Biosciences Corp Earnings Call This WeekPairCorr
  0.47KTTAW Pasithea TherapeuticsPairCorr
  0.46VXRT Vaxart IncPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

LXEOANRO
CLLSENGN
LXEOENGN
CLLSANNX
ANROALT
CLLSLXEO
  

High negative correlations

ANROLRMR
ANROKRRO
LBRXALT
KRROALT
ALTLRMR
LBRXLRMR

Risk-Adjusted Indicators

There is a big difference between DBV Stock performing well and DBV Technologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze DBV Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
LRMR  4.64  0.08  0.01  0.08  7.66 
 8.72 
 48.59 
ANNX  4.34  1.18  0.29  0.70  3.39 
 11.35 
 28.94 
ALT  2.50  0.34  0.13  0.54  2.36 
 6.18 
 13.65 
KRRO  6.74 (0.48) 0.00 (0.06) 0.00 
 12.19 
 97.43 
ENGN  6.62  1.17  0.15  0.23  7.61 
 18.10 
 61.40 
AMRN  1.81  0.14  0.04 (0.72) 2.75 
 3.56 
 23.79 
ANRO  7.45  2.72  0.40  0.39  6.10 
 11.36 
 100.99 
LXEO  3.49  1.05  0.30  1.04  2.71 
 7.04 
 38.59 
CLLS  4.20  0.73  0.15  8.99  4.46 
 9.98 
 27.39 
LBRX  2.87 (0.12) 0.00 (0.27) 0.00 
 5.76 
 20.98 

DBV Technologies Corporate Management

PharmD DChief OfficerProfile
Joseph BeckerVP CommunicationsProfile
Sbastien RobitailleChief OfficerProfile
Wence AgbotounouChief Clinical Trial OfficerProfile
Caroline DaniereChief StaffProfile
Daniel TassCEO DirectorProfile